Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Cases. Dec 16, 2014; 2(12): 866-872
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.866
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.866
Table 1 Risk factors of malignant transformation
| Female gender |
| Long duration of leukoplakia |
| Leukoplakia in non-smokers |
| Location on the tongue and/or floor of the mouth |
| Size > 200 mm2 |
| Non-homogenous type |
| Presence of epithelial dysplasia |
Table 2 Miscellaneous treatment regimens for oral lichen planus
| Topical treatments | Systemic treatments | Surgery |
| Corticosteroids (triamcinolone, fluocinolone acetonide, fluocinonide, clobetasol, fluticasone propionate, betamethasone sodium phosphate, mometasone furoate) Cyclosporin Tacrolimus Pimekrolimus Rapamycin (sirolimus) Retinoids (tretinoin, isotretinoin) Aloe vera Hyaluronic acid 0.2% gel | Corticosteroids Acitretin Azathioprine Basiliximab Cyclosporin Dapsone Eiconol Enoxaparin Glycyrrhizin Hydroxychloroquine Interferon alpha Levamisole Mycophenolate mofetil Thalidomide Tetracycline Mesalazine Phenytoin Griseofulvin | Resection Cryotherapy Lasers (CO2, excimer laser) |
Table 3 Clinical and functional staging
| Clinical stage | Functional stage |
| Faucial bands only | Mouth opening ≥ 20 mm |
| Faucial and buccal bands | Mouth opening 11-19 mm |
| Faucial, buccal, and labial bands | Mouth opening ≤ 10 mm |
- Citation: Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa. World J Clin Cases 2014; 2(12): 866-872
- URL: https://www.wjgnet.com/2307-8960/full/v2/i12/866.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v2.i12.866
